Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer
NCT ID: NCT04622176
Last Updated: 2023-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
28 participants
OBSERVATIONAL
2021-06-17
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with rectal cancer
Patients with rectal cancer will be included and asked to participate in the study where a MMUS will be used after resection to test diagnostic accuracy.
MMUS
MMUS will be used to perform diagnostics, we will compare with MRI and histology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MMUS
MMUS will be used to perform diagnostics, we will compare with MRI and histology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgery with abdominoperineal resection
* No rectal cancer
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Angenete
Professor of surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Angenete
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska Universitetssjukhuset
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eva Angenete, MD,PhD
Role: primary
Erik
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMURC
Identifier Type: -
Identifier Source: org_study_id